Talquetamab vs Real-World Physician's Choice in Patients With Relapsed/Refractory Multiple Myeloma and Prior B-Cell Maturation Antigen Therapy: Analyses of MonumenTAL-1 vs LocoMMotion/MoMMent

被引：0

作者：

Mateos Manteca, Maria-Victoria ^{[1
]}

Jakubowiak, Andrzej ^{[2
]}

Einsele, Hermann ^{[3
]}

Schinke, Carolina ^{[4
]}

Besemer, Britta ^{[5
]}

Anguille, Sebastien ^{[6
]}

Manier, Salomon ^{[7
]}

Rasche, Leo ^{[8
]}

Goldschmidt, Hartmut ^{[9
]}

van de Donk, Niels ^{[10
,11
]}

Perrot, Aurore ^{[12
]}

Teipel, Raphael ^{[13
]}

Karlin, Lionel ^{[14
]}

Scheid, Christof ^{[15
]}

San-Miguel, Jesus ^{[16
]}

Pawlyn, Charlotte ^{[17
,18
]}

Martinez-Lopez, Joaquin ^{[19
]}

Cavo, Michele ^{[20
]}

Diels, Joris ^{[21
]}

Renaud, Thomas ^{[22
]}

Orel, Oleksiy ^{[23
]}

Cabrieto, Jedelyn ^{[21
]}

Perualila, Nolen ^{[21
]}

Weisel, Katja ^{[24
]}

Moreau, Philippe ^{[25
]}

机构：

[1] Univ Hosp Salamanca, Inst Biomed Res Salamanca IBSAL, CIBERONC, Salamanca, Spain

[2] Univ Chicago, Chicago, IL USA

[3] Univ Wurzburg, Med Klin & Poliklin 2, Wurzburg, Germany

[4] Univ Arkansas Med Sci, Myeloma Ctr, Little Rock, AR USA

[5] Univ Tubingen, Tubingen, Germany

[6] Univ Antwerp, Antwerp Univ Hosp, Ctr Cell Therapy & Regenerat Med, Vaccine & Infect Dis Inst, Antwerp, Belgium

[7] Univ Lille, CHU Lille, Lille, France

[8] Univ Hosp Wurzburg, Wurzburg, Germany

[9] Univ Hosp Heidelberg, GMMG Study Grp, Dept Internal Med 5, Heidelberg, Germany

[10] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands

[11] Canc Ctr Amsterdam, Amsterdam, Netherlands

[12] Univ Toulouse, Serv Hematol, Toulouse, France

[13] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, Dresden, Germany

[14] Ctr Hosp Lyon Sud, Lyon, France

[15] Univ Hosp Cologne, Dept Internal Med 1, Cologne, Germany

[16] Clin Univ Navarra, Navarra, Spain

[17] Inst Canc Res, London, England

[18] Royal Marsden NHS Fdn Trust, London, England

[19] Univ Complutense Madrid, CNIO Clin Res Unit H12O, CIBERONC, Dept Hematol,Hosp 12 Octubre, Madrid, Spain

[20] Univ Bologna, IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[21] Janssen Pharmaceut NV, Beerse, Belgium

[22] Janssen Res & Dev, Raritan, NJ USA

[23] Janssen Cilag GmbH, Neuss, Germany

[24] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

[25] Univ Hosp Hotel Dieu, Hematol Dept, Beirut, Lebanon

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-050

引用

页码：S69 / S70

页数：2

共 50 条

[41] DURABLE RESPONSES FOLLOWING CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/ REFRACTORY LARGE B-CELL LYMPHOMA AFTER MULTIPLE LINES OF TREATMENT: THE HELLENIC REAL-WORLD EXPERIENCE
Bampali, Vasiliki
Dolgyras, Panagiotis
Matheakakis, Angelos
Alexandropoulos, Alexandros
Tsonis, Ioannis
Gavriilaki, Eleni
Tzannou, Ifigeneia
Batsis, Ioannis
Tzenou, Tatiana
Mallouri, Despina
Bouzani, Maria
Vardi, Anna
Anagnostopoulos, Achilles
Gigantes, Stavros
Sotiropoulos, Damianos
Karakasis, Dimitrios
Baltadakis, Ioannis
Sakellari, Ioanna
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 211 - 211
[42] Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy
Charkviani, Mariam
Vaughan, Lisa E.
Sandahl, Tyler B.
Lin, Yi
Leung, Nelson
Herrmann, Sandra M.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[43] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
Charanpreet Singh
Aditya Jandial
Arihant Jain
Deepesh Lad
Alka Khadwal
Rajender Basher
Amanjit Bal
Pankaj Malhotra
Gaurav Prakash
Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 231 - 236
[44] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
Singh, Charanpreet
Jandial, Aditya
Jain, Arihant
Lad, Deepesh
Khadwal, Alka
Basher, Rajender
Bal, Amanjit
Malhotra, Pankaj
Prakash, Gaurav
INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (02) : 231 - 236
[45] Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma
Zhao, Wan-Hong
Liu, Jie
Wang, Bai-Yan
Chen, Yin-Xia
Cao, Xing-Mei
Yang, Yun
Zhang, Yi-Lin
Wang, Fang-Xia
Zhang, Peng-Yu
Lei, Bo
Gu, Liu-Fang
Wang, Jian-Li
Yang, Nan
Zhang, Ru
Zhang, Hui
Shen, Ying
Bai, Ju
Xu, Yan
Wang, Xu-Geng
Zhang, Rui-Li
Wei, Li-Li
Li, Zong-Fang
Li, Zhen-Zhen
Geng, Yan
He, Qian
Zhuang, Qiu-Chuan
Fan, Frank Xiao-Hu
He, Ai-Li
Zhang, Wang-Gang
BLOOD, 2018, 132
[46] A 5-Year Follow-up Clinical Study of the B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy HDS269B in Patients with Relapsed or Refractory Multiple Myeloma
Chen, Dongjian
Zhu, Yu
Chen, Zhi
Jiang, Songfu
He, Haiyan
Qiang, Wanting
Xiang, Fang
Sun, Xuedong
Du, Juan
CLINICAL CANCER RESEARCH, 2024, 30 (17) : 3747 - 3756
[47] Efficacy and safety of elranatamab in pts with relapsed/ refractory multiple myeloma (RRMM) and prior B-cell maturation antigen (BCMA)-directed therapies: a pooled analysis from MagnetisMM studies
Raab, M. S.
Hanel, M.
Nooka, A. K.
Lesokhin, A. M.
Mohty, M.
Niesvizky, R.
Maisel, C.
Arnulf, B.
Larson, S. M.
Varshavsky-Yanovsky, A. N.
Leleu, X.
Karlin, L.
Vesole, D. H.
Bahlis, N. J.
de larrea, Fernandez C.
Raje, N.
Leip, E.
Conte, U.
Elmeliegy, M.
Viqueira, A.
Manier, S.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 232 - 232
[48] Real-World Evaluation of Outcomes in Relapsed/Refractory Multiple Myeloma Patients That Are Triple-Class Exposed after Receiving 2 or More Prior Lines of Therapy
Radwanski, Katherine
Yu, Junhua
Pierce, Kody
Talati, Chetasi
Stricker, Steve
Jiao, Shiyin
Bueno, Orlando
BLOOD, 2023, 142
[49] Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Bonifacio, Massimiliano
Papayannidis, Cristina
Lussana, Federico
Fracchiolla, Nicola
Annunziata, Mario
Sica, Simona
Delia, Mario
Foa, Robin
Pizzolo, Giovanni
Chiaretti, Sabina
FRONTIERS IN ONCOLOGY, 2022, 11
[50] Effect of Prior Selinexor Exposure on Clinical Outcomes of Chimeric Antigen Receptor T-cell (CAR-T) Therapy for Relapsed/Refractory Multiple Myeloma (RRMM): A Real-World Descriptive Analysis
Costa, Bruno
Khouri, Jack
Mark, Tomer
Ijioma, Stephen
Ray, David
Dranitsaris, George
Sadek, Norah
Dima, Danai
Moshier, Erin
Mouhieddine, Tarek
Sheng, Tianxiang
Rossi, Adriana
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S256 - S256

← 1 2 3 4 5 →